Clik here to view.
Intuitive Surgical shares rise amid takeover rumors
Intuitive Surgical (NSDQ:ISRG) stocks are up today on rumors that the company may be looking at a takeover from a larger player in medtech. Shares have ticked up nearly 1%, up $7.11 at $769.45 today...
View ArticleClik here to view.
Shockwave Medical launches lithoplasty trial
Shockwave Medical said today it enrolled the 1st patient in the Disrupt PAD III trial of its Lithoplasty system, aiming to explore the system’s effectiveness at treating heavily calcified lesions in...
View ArticleClik here to view.
Liposomal drug delivery system could improve solid tumor treatment
The oxygen-poor regions of solid tumors usually help make them resistant to chemotherapy and other forms of treatment. But researchers at Oregon State University have devised away to take advantage of...
View ArticleClik here to view.
UK Medical in management buyout from BD
The management of Becton Dickinson & Co. (NYSE:BDX) subsidiary UK Medical bought the company from its parent for an undisclosed amount. The Sheffield, U.K.-based company, which was acquired by...
View ArticleClik here to view.
Endologix inks $170m credit facility with Deerfield
Endologix (NSDQ:ELGX) said this week it inked a credit facility worth up to $170 million with Deerfield Management. Money in the facility will be provided through a $120 million 6-year secured term...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for April 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Triple inhaler reduces COPD flare-ups by 20%
Researchers at the University of Manchester found that flare-ups in chronic obstructive pulmonary disease can be reduced by 20% with a combined triple inhaler. The team’s work was published in the...
View ArticleClik here to view.
ISHLT 2017: Medtronic HVAD trial misses primary endpoint, reports lowered...
Medtronic (NYSE:MDT) said today that results from the Endurance supplemental trial of its HVAD heart pump system did not meet its primary endpoint, but did report lowered stroke rates compared to...
View ArticleClik here to view.
Acelity taps Eckert for prez, CEO | Personnel Moves, April 5, 2017
Acelity said today it tapped R. Eckert as its new prez & CEO, succeeding Joseph Woody who is stepping away from Acelity following the company’s divestiture of its LifeCell division earlier this...
View ArticleClik here to view.
Neural interface developer Synchron raises $10m in Series A
Minimally invasive neuromod developer Synchron said today it raised $10 million in a Series A round of financing to support its neural interface technology. The round was led by Neurotechnology...
View ArticleClik here to view.
Medtronic, Washington U land $3m NIH grant for brain-function mapping dev
A collaborative 3D brain-mapping project between the Washington University School of Medicine in St. Louis and Medtronic (NYSE:MDT) has received a $3.6 million grant from the National Cancer Institute...
View ArticleClik here to view.
Gurnet Point buys Innocoll holdings for $209m
Healthcare investment fund Gurnet Point said today it will acquire Innocoll Holdings for approximately $209 million. Gurnet will put up $1.75 per share in cash and up to $4.90 in cash from a contingent...
View ArticleClik here to view.
Neural Analytics raises $10m
Neural Analytics raised $10.1 million in a new round of equity and options financing, according to an SEC filing posted this week. The Los Angeles-based company develops the Lucid M1, a portable...
View ArticleClik here to view.
Cardinal Health closes in on $6B deal for Medtronic’s medical supplies biz
Cardinal Health (NYSE:CAH) close to acquiring the medical supplies business deal to pay $6 billion for the medical supplies business Medtronic (NYSE:MDT) acquired when it paid $50 billion for Covidien...
View ArticleClik here to view.
Saudi Food and Drug Authority plans changes for medical device marketing...
By Stewart Eisenhart, Emergo Group Saudi Arabia’s medical device regulator, the Saudi Food and Drug Authority (SFDA), plans to introduce changes to the application process for obtaining market...
View ArticleClik here to view.
FDA nominee Gottlieb grilled over industry ties
It wasn’t all that long ago that Dr. Robert Califf, the Obama administration’s nominee to head the FDA, was grilled for his close ties to the pharmaceutical industry. Yesterday, it was the turn of the...
View ArticleClik here to view.
SteadyMed studies accuracy and precision of PatchPump infusion system for...
SteadyMed (NSDQ:STDY) said yesterday that it finished a clinical study for its lead drug candidate, Trevyent. The pulmonary arterial hypertension treatment is a combination of treprostinil and the...
View ArticleClik here to view.
B. Braun launches app for Easypump home infusion therapy
B. Braun launched an app yesterday for its Easypump ST/LT elastomeric infusion pump to help patients and clinicians use the system more safely and efficiently for home infusion therapy. The Easypump...
View ArticleClik here to view.
German billionaire Hopp readies sale of skin patch maker LTS
German billionaire Dietmar Hopp is reportedly preparing to sell medical skin patch maker LTS Lohmann as he looks to shake-up his investment porfolio. LTS has 1,300 employees and brings in more than 300...
View ArticleClik here to view.
Defendants move for acquittal in Abbott-Advanced Medical Optics insider...
The defendants in an insider trading case yesterday asked a federal judge in California to acquit them of all charges, arguing that the government failed to show any evidence that they traded on inside...
View Article